| Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Diabetes | 2008 | 3.1K |
| Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 2.5K |
| Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics | Nature Reviews Gastroenterology and Hepatology | 2017 | 2K |
| Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Gut | 2009 | 1.6K |
| Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia | Diabetologia | 2007 | 1.2K |
| Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Gut | 2016 | 938 |
| A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice | Nature Medicine | 2017 | 896 |
| Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice | Diabetes | 2011 | 701 |
| Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study | Nature Medicine | 2019 | 650 |
| The role of the gut microbiota in energy metabolism and metabolic disease | Current Pharmaceutical Design | 2009 | 636 |
| Human gut microbiome: hopes, threats and promises | Gut | 2018 | 599 |
| Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling | Cell Metabolism | 2015 | 562 |
| Targeting gut microbiota in obesity: effects of prebiotics and probiotics | Nature Reviews Endocrinology | 2011 | 540 |
| Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity | Gut Microbes | 2012 | 527 |
| Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women | Gut | 2013 | 517 |
| Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal | American Journal of Clinical Nutrition | 2009 | 502 |
| Towards a more comprehensive concept for prebiotics | Nature Reviews Gastroenterology and Hepatology | 2015 | 490 |
| Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice | Scientific Reports | 2015 | 464 |
| Next-Generation Beneficial Microbes: The Case of | Frontiers in Microbiology | 2017 | 459 |
| Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 455 |
| Human Intestinal Barrier Function in Health and Disease | Clinical and Translational Gastroenterology | 2016 | 396 |
| Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice | FASEB Journal | 2008 | 386 |
| Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity | ISME Journal | 2014 | 376 |
| Diabetes, obesity and gut microbiota | Bailliere's Best Practice and Research in Clinical Gastroenterology | 2013 | 360 |
| Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells | Journal of Clinical Investigation | 1992 | 349 |
